Skip to content

Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease

Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06525415
Enrollment
30
Registered
2024-07-29
Start date
2024-08-01
Completion date
2024-11-30
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perfusion, Peripheral Arterial Disease

Brief summary

We investigate the peri-operative foot perfusion through dynamic contrast enhanced MRI in patients with peripheral artery disease

Interventions

DIAGNOSTIC_TESTDCE MRI

the recruited patients should complete pre- and post-operative DCE MRI workshops

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 80 years old; * PAD patients with Fontaine grade II-IV or Rutherford grade 2-6 and underwent a successful revascularization; * Patients completed both pre- and post-operative MRI workups; * Patients signed the informed consent form and be able to complete the clinical follow-up for 1 months.

Exclusion criteria

* Patients has participated in other clinical studies; * Patients with Heart failure (NYHA III/IV)/right to left shunt heart disease/ severe aortic and mitral insufficiency/acute coronary syndrome/malignant arrhythmia/severe pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)/moderate to severe renal insufficiency (creatinine clearance rate\<60 ml/min) * Any allergic constitution; * Pregnancy and childbirth; * Life expectancy\<12 months.

Design outcomes

Primary

MeasureTime frameDescription
preoperative perfusion parametersBetween Aug.1 2024 and OCT.31 2024preoperative perfusion parameters by dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI)

Secondary

MeasureTime frame
ankle brachial indexBetween Aug.1 2024 and OCT.31 2024
clinical successBetween Aug.1 2024 and NOV.30 2024
survivalBetween Aug.1 2024 and NOV.30 2024

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026